VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer

NCT06337695 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

298

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Cancer Metastatic

Interventions

BIOLOGICAL: Vedolizumab
BIOLOGICAL: Placebo

Sponsor

University of Calgary